XML 85 R54.htm IDEA: XBRL DOCUMENT
v3.23.2

Investments in Other Entities - Schedule of Equity Method Investments (Details) - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended
--- | --- | ---
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 43,108 | $ 44,383 | $ 40,299 | $ 41,715
Initial Investment | 0 |  | 325 |
Allocation of Income (Loss) | 2,723 | 1,512 | 5,207 | 2,945
Funding Reclassified To Loan Receivable |  | (2,125) |  | (2,125)
Funding | 0 | 250 | 0 | 1,685
Distribution | 0 | (200) | 0 | (400)
Ending Balance | $ 45,831 | $ 43,820 | $ 45,831 | $ 43,820
LaSalle Medical Associates – IPA Line of Business |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest | 25.00% | 25.00% | 25.00% | 25.00%
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 7,848 | $ 4,292 | $ 5,684 | $ 3,034
Initial Investment | 0 |  | 0 |
Allocation of Income (Loss) | 2,689 | 1,277 | 4,853 | 2,535
Funding Reclassified To Loan Receivable |  | (2,125) |  | (2,125)
Funding | 0 | 0 | 0 | 0
Distribution | 0 | 0 | 0 | 0
Ending Balance | $ 10,537 | $ 3,444 | $ 10,537 | $ 3,444
Pacific Medical Imaging & Oncology Center, Inc. |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest | 40.00% | 40.00% | 40.00% | 40.00%
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 1,886 | $ 1,726 | $ 1,878 | $ 1,719
Initial Investment | 0 |  | 0 |
Allocation of Income (Loss) | (231) | 15 | (223) | 22
Funding Reclassified To Loan Receivable |  | 0 |  | 0
Funding | 0 | 0 | 0 | 0
Distribution | 0 | 0 | 0 | 0
Ending Balance | $ 1,655 | $ 1,741 | $ 1,655 | $ 1,741
531 W. College, LLC |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest | 50.00% | 50.00% | 50.00% | 50.00%
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 17,191 | $ 17,048 | $ 17,281 | $ 17,230
Initial Investment | 0 |  | 0 |
Allocation of Income (Loss) | (121) | (123) | (211) | (305)
Funding Reclassified To Loan Receivable |  | 0 |  | 0
Funding | 0 | 250 | 0 | 250
Distribution | 0 | 0 | 0 | 0
Ending Balance | $ 17,070 | $ 17,175 | $ 17,070 | $ 17,175
One MSO, LLC |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest | 50.00% | 50.00% | 50.00% | 50.00%
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 2,833 | $ 2,847 | $ 2,718 | $ 2,910
Initial Investment | 0 |  | 0 |
Allocation of Income (Loss) | 127 | 117 | 242 | 254
Funding Reclassified To Loan Receivable |  | 0 |  | 0
Funding | 0 | 0 | 0 | 0
Distribution | 0 | (200) | 0 | (400)
Ending Balance | $ 2,960 | $ 2,764 | $ 2,960 | $ 2,764
CAIPA MSO, LLC |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest | 30.00% | 30.00% | 30.00% | 30.00%
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 12,988 | $ 12,140 | $ 12,738 | $ 11,992
Initial Investment | 0 |  | 0 |
Allocation of Income (Loss) | 201 | 180 | 451 | 328
Funding Reclassified To Loan Receivable |  | 0 |  | 0
Funding | 0 | 0 | 0 | 0
Distribution | 0 | 0 | 0 | 0
Ending Balance | $ 13,189 | $ 12,320 | $ 13,189 | $ 12,320
James Song, M.D., A Professional Corporation |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest | 25.00% |  | 25.00% |
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance | $ 362 |  | $ 0 |
Initial Investment | 0 |  | 325 |
Allocation of Income (Loss) | 58 |  | 95 |
Funding | 0 |  | 0 |
Distribution | 0 |  | 0 |
Ending Balance | $ 420 |  | $ 420 |
Tag-6 Medical Investment Group, LLC |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |
Ownership interest |  | 50.00% |  | 50.00%
Equity Method Investments [Roll Forward] |  |  |  |
Beginning Balance |  | $ 6,330 |  | $ 4,830
Allocation of Income (Loss) |  | 46 |  | 111
Funding Reclassified To Loan Receivable |  | 0 |  | 0
Funding |  | 0 |  | 1,435
Distribution |  | 0 |  | 0
Ending Balance |  | $ 6,376 |  | $ 6,376

X
- Definition Equity Method Investment, Additional Investment + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentAdditionalInvestment
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investment, Funding Reclassified to Loan Receivable + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentFundingReclassifiedToLoanReceivable
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments, Contribution + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsContribution
Namespace Prefix: | ameh_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Equity Method Investments [Roll Forward] + References No definition available. + Details
Name: | ameh_EquityMethodInvestmentsRollForward
Namespace Prefix: | ameh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of the entity's equity method investment which has been sold. + References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentSoldCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(12)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(13)(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1 + Details
Name: | us-gaap_IncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_LasalleMedicalAssociatesIpaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_PacificMedicalImagingAndOncologyCenterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_FiveThreeOneW.CollegeLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_OneMSOLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_CAIPAMSOLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_JamesSongMDAProfessionalCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=ameh_Tag6MedicalInvestmentGroupLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |